Jacqueline Valenzuela Rangel¹*, Itzel Cabrera Yepez¹ and Dra María Montserrat López Ortíz²

¹Students of Nutrition at the Universidad de Guanajuato, Campus León, Mexico
²Researcher and full-time professor of the Department of Medicine and Nutrition at the Universidad de Guanajuato. Contact: Department of Medicine and Nutrition, Division of Health Sciences, Campus León. Universidad de Guanajuato, Mexico

*Corresponding Author: Jacqueline Valenzuela Rangel, Students of Nutrition at the Universidad de Guanajuato, Campus León, Mexico.

Received: March 16, 2022; Published: April 11, 2022

Abstract

It is common to hear about the liver, and how this organ can easily get sick or damaged by excessive alcohol consumption. However, there is a condition that is not necessarily related to alcohol intake, this is non-alcoholic fatty liver disease (NAFLD), and it can be prevented or modified in its early stages of evolution [1].

Keywords: Non-Alcoholic Fatty Liver Disease (NAFLD); Metabolic Syndrome; Hepatocyte; Omega-3:

References

1. Janczyk W., et al. “Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial”. The Journal of Pediatrics 6 (2015): 1358-1363.
2. Coronel E and Coronel M. “Esteatohepatitis no alcohólica (EHNA)”. Revista de Gastroenterología del Perú 1 (2016): 58-65.
3. Castellanos L and Rodríguez M. “El efecto de Omega 3 en la salud humana y consideraciones en la ingesta”. Revista Chilena de Nutricion 1 (2015): 90-95.
4. Secretaria de Salud, Instituto Nacional de Salud Pública. “Encuesta Nacional de Salud y Nutrición de Medio Camino 2016”. Informe Final de Resultados (2016).
5. Bernal R., et al. “Consenso mexicano de la enfermedad por hígado graso no alcohólico”. Revista de Gastroenterología de México 1 (2019): 69-99.
6. Hernández M., et al. “Beneficios de los ácidos grasos poliinsaturados de cadena larga n-3 en la enfermedad por hígado graso no alcohólico”. Revista Chilena de Nutrición 2 (2016): 196-205.
7. Parker HM., et al. “Omega-3 supplementation and non-alcoholic fatty liver disease: a systematic review and meta-analysis”. Journal of Hepatology 4 (2012): 944-951.
8. Boyraz M., et al. “Long-Term Treatment with n-2 Polyunsaturated Fatty Acids as a Monotherapy in Children with Nonalcoholic Fatty Liver Disease”. Journal of Clinical Research in Pediatric Endocrinology 2 (2015): 121-127.
9. Aller R., et al. “Nutrición en el hígado graso no alcohólico”. Nutrition in Clinical Medicine2 (2019): 89-98.

Citation

Citation: Jacqueline Valenzuela Rangel., et al. “The Consumption of Omega-3 as Part of the Treatment and Prevention of Non-Alcoholic Fatty Liver Disease (NAFLD)". Acta Scientific Nutritional Health 6.5 (2022): 27-30.

Copyright

Copyright: © 2022 Jacqueline Valenzuela Rangel., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.